InspireMD, Inc.

NSPR Nasdaq CIK: 0001433607

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 6303 WATERFORD DISTRICT DRIVE, MIAMI, FL, 33126
Mailing Address 6303 WATERFORD DISTRICT DRIVE, MIAMI, FL, 33126
Phone (888) 776-6804
Fiscal Year End 1231
EIN 262123838

Financial Overview

FY2025

-$32.01M
Net Income
$55.20M
Stockholders' Equity
$18.92M
Cash & Equivalents
$-0.76
EPS

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events March 18, 2026 View on SEC
10-K Annual financial report March 18, 2026 View on SEC
8-K Current report of material events March 4, 2026 View on SEC
4/A Insider transaction amendment February 23, 2026 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) February 17, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 11, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 2, 2026 View on SEC
4 Insider stock transaction report February 2, 2026 View on SEC
4 Insider stock transaction report January 16, 2026 View on SEC
4 Insider stock transaction report January 16, 2026 View on SEC

Annual Reports

10-K March 18, 2026
  • InspireMD develops and commercializes medical devices for vascular conditions, with flagship CGuard™ EPS for stroke prevention.
  • CGuard EPS offers unique design and clinical benefits for superior embolic protection compared to conventional stents.
View Analysis

Insider Trading

SELL 2 insiders 14 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.